129 related articles for article (PubMed ID: 20882255)
21. Half-sandwich Ru II[9]aneS3 complexes structurally similar to antitumor-active organometallic piano-stool compounds: preparation, structural characterization and in vitro cytotoxic activity.
Bratsos I; Jedner S; Bergamo A; Sava G; Gianferrara T; Zangrando E; Alessio E
J Inorg Biochem; 2008; 102(5-6):1120-33. PubMed ID: 18279961
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and cellular impact of diene-ruthenium(II) complexes: a new class of organoruthenium anticancer agents.
Kasper C; Alborzinia H; Can S; Kitanovic I; Meyer A; Geldmacher Y; Oleszak M; Ott I; Wölfl S; Sheldrick WS
J Inorg Biochem; 2012 Jan; 106(1):126-33. PubMed ID: 22115828
[TBL] [Abstract][Full Text] [Related]
23. Hemilabile β-aminophosphine ligands derived from 1,3,5-triaza-7-phosphaadamantane: application in aqueous ruthenium catalyzed nitrile hydration.
Lee WC; Sears JM; Enow RA; Eads K; Krogstad DA; Frost BJ
Inorg Chem; 2013 Feb; 52(4):1737-46. PubMed ID: 23356543
[TBL] [Abstract][Full Text] [Related]
24. Acetylcholine-like and trimethylglycine-like PTA (1,3,5-triaza-7-phosphaadamantane) derivatives for the development of innovative Ru- and Pt-based therapeutic agents.
Ferretti V; Fogagnolo M; Marchi A; Marvelli L; Sforza F; Bergamini P
Inorg Chem; 2014 May; 53(10):4881-90. PubMed ID: 24801393
[TBL] [Abstract][Full Text] [Related]
25. In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes.
Scolaro C; Bergamo A; Brescacin L; Delfino R; Cocchietto M; Laurenczy G; Geldbach TJ; Sava G; Dyson PJ
J Med Chem; 2005 Jun; 48(12):4161-71. PubMed ID: 15943488
[TBL] [Abstract][Full Text] [Related]
26. Ruthenium(II) arene PTA (RAPTA) complexes: impact of enantiomerically pure chiral ligands.
Kilpin KJ; Cammack SM; Clavel CM; Dyson PJ
Dalton Trans; 2013 Feb; 42(6):2008-14. PubMed ID: 23187957
[TBL] [Abstract][Full Text] [Related]
27. A novel ruthenium(II) arene based intercalator with potent anticancer activity.
Ruiz J; Vicente C; de Haro C; Bautista D
Dalton Trans; 2009 Jul; (26):5071-3. PubMed ID: 19562164
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, antimicrobial and antiproliferative activity of novel silver(I) tris(pyrazolyl)methanesulfonate and 1,3,5-triaza-7-phosphadamantane complexes.
Pettinari C; Marchetti F; Lupidi G; Quassinti L; Bramucci M; Petrelli D; Vitali LA; da Silva MF; Martins LM; Smoleński P; Pombeiro AJ
Inorg Chem; 2011 Nov; 50(21):11173-83. PubMed ID: 21999582
[TBL] [Abstract][Full Text] [Related]
29. Selective, cytotoxic organoruthenium(II) full-sandwich complexes: a structural, computational and in vitro biological study.
Loughrey BT; Cunning BV; Healy PC; Brown CL; Parsons PG; Williams ML
Chem Asian J; 2012 Jan; 7(1):112-21. PubMed ID: 22095971
[TBL] [Abstract][Full Text] [Related]
30. The influence of RAPTA moieties on the antiproliferative activity of peripheral-functionalised poly(salicylaldiminato) metallodendrimers.
Govender P; Sudding LC; Clavel CM; Dyson PJ; Therrien B; Smith GS
Dalton Trans; 2013 Jan; 42(4):1267-77. PubMed ID: 23143220
[TBL] [Abstract][Full Text] [Related]
31. New cytotoxic and water-soluble bis(2-phenylazopyridine)ruthenium(II) complexes.
Hotze AC; Bacac M; Velders AH; Jansen BA; Kooijman H; Spek AL; Haasnoot JG; Reedijk J
J Med Chem; 2003 Apr; 46(9):1743-50. PubMed ID: 12699392
[TBL] [Abstract][Full Text] [Related]
32. Rhodium, iridium, and ruthenium half-sandwich picolinamide complexes as anticancer agents.
Almodares Z; Lucas SJ; Crossley BD; Basri AM; Pask CM; Hebden AJ; Phillips RM; McGowan PC
Inorg Chem; 2014 Jan; 53(2):727-36. PubMed ID: 24397747
[TBL] [Abstract][Full Text] [Related]
33. Anthracene-tethered ruthenium(II) arene complexes as tools to visualize the cellular localization of putative organometallic anticancer compounds.
Nazarov AA; Risse J; Ang WH; Schmitt F; Zava O; Ruggi A; Groessl M; Scopelitti R; Juillerat-Jeanneret L; Hartinger CG; Dyson PJ
Inorg Chem; 2012 Mar; 51(6):3633-9. PubMed ID: 22394115
[TBL] [Abstract][Full Text] [Related]
34. DNA interactions of monofunctional organometallic ruthenium(II) antitumor complexes in cell-free media.
Novakova O; Chen H; Vrana O; Rodger A; Sadler PJ; Brabec V
Biochemistry; 2003 Oct; 42(39):11544-54. PubMed ID: 14516206
[TBL] [Abstract][Full Text] [Related]
35. Amide linkage isomerism as an activity switch for organometallic osmium and ruthenium anticancer complexes.
van Rijt SH; Hebden AJ; Amaresekera T; Deeth RJ; Clarkson GJ; Parsons S; McGowan PC; Sadler PJ
J Med Chem; 2009 Dec; 52(23):7753-64. PubMed ID: 19791745
[TBL] [Abstract][Full Text] [Related]
36. Arene ruthenium complexes as anticancer agents.
Süss-Fink G
Dalton Trans; 2010 Feb; 39(7):1673-88. PubMed ID: 20449402
[TBL] [Abstract][Full Text] [Related]
37. Novel ruthenium azo-quinoline complexes with enhanced photonuclease activity in human cancer cells.
Kaulage MH; Maji B; Pasadi S; Bhattacharya S; Muniyappa K
Eur J Med Chem; 2017 Oct; 139():1016-1029. PubMed ID: 28910739
[TBL] [Abstract][Full Text] [Related]
38. Anticancer activity of ruthenium(II) arene complexes bearing 1,2,3,4-tetrahydroisoquinoline amino alcohol ligands.
Chelopo MP; Pawar SA; Sokhela MK; Govender T; Kruger HG; Maguire GE
Eur J Med Chem; 2013 Aug; 66():407-14. PubMed ID: 23827181
[TBL] [Abstract][Full Text] [Related]
39. Study of ruthenium(II) complexes with anticancer drugs as ligands. Design of metal-based phototherapeutic agents.
Cini R; Tamasi G; Defazio S; Corsini M; Zanello P; Messori L; Marcon G; Piccioli F; Orioli P
Inorg Chem; 2003 Dec; 42(24):8038-52. PubMed ID: 14632524
[TBL] [Abstract][Full Text] [Related]
40. DNA structural distortions induced by ruthenium-arene anticancer compounds.
Gossens C; Tavernelli I; Rothlisberger U
J Am Chem Soc; 2008 Aug; 130(33):10921-8. PubMed ID: 18651736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]